Kinapse welcomes you to ICH Q12

On 9th April 2020, Swissmedic published an update on the implementation of ICH Q12 in Switzerland. As an ICH member Switzerland also follows the EMA in implementing this guideline. Swissmedic applies this guideline, with restrictions concerning “established conditions” and the “PLCM” (Product Life Cycle Management) document, to all applications submitted from 1st April 2020 onwards. Follow the link for the full update.

Kinapse welcomes you to ICH Q12 – March 2020
Kinapse welcomes you to ICH Q12 – December 2019
Kinapse Contributes to Guideline ICH Q12 Comments

Share this page:

Check ICH Q12 related posts